Moderate Support for Anti-Amyloid Alzheimer’s Drugs in Meta-Analysis
Physician's Weekly,
Small clinical improvements, large biomarker changes, and major risk for…
Small clinical improvements, large biomarker changes, and major risk for…
Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s…
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new…
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new…